PYRIMETHAMINE MARKET ANALYSIS

Pyrimethamine Market, By Dosage Form (Tablets and Capsules), By Strength (25 mg, 50 mg, 75 mg, and Others), By Indication (Malaria, Toxoplasmosis, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Feb 2025
Code : CMI4948
Pages :178
Formats :
Excel and PDF
Industry : Pharmaceutical

Pyrimethamine Market Size and Trends

The pyrimethamine market is estimated to be valued at USD 1.28 Bn in 2025 and is expected to reach USD 1.87 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032.

Pyrimethamine Market Key Factors

To learn more about this report, Request sample copy

The increasing prevalence of malaria globally is expected to drive the demand for pyrimethamine. Pyrimethamine is prescribed by doctors as a combination therapy for malaria treatment. Furthermore, the unmet needs in malaria endemic regions will also boost the adoption of effective medications like pyrimethamine. However, factors such as lack of awareness regarding malaria prevention in developing countries and development of parasite resistance to existing drugs can hamper the market growth during the forecast period.